Pleco Therapeutics Announces Positive Outcome of Pre-IND meeting with FDA for PTX-252 in Acute Myeloid Leukaemia
NIJMEGEN, The Netherlands, March 26, 2025 (GLOBE NEWSWIRE) -- Pleco Therapeutics, a…
FDA Issues Nyxoah an Approvable Letter for its Genio System
INSIDE INFORMATIONREGULATED INFORMATION FDA Issues Nyxoah an Approvable Letter for its Genio®…
ONWARD Medical Announces First-in-Human Use of ARC-IM Lumbar Lead Designed to Restore Standing, Stepping, and Lower Limb Mobility
The ARC-IM Lumbar Lead is the second model in the ARC-IM Lead…
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
Chlamydia vaccine candidate granted fast track designation by the US FDA Chlamydia…
BioVersys Reports Corporate Highlights and Key Financials for the Full Year 2024
March 26, 2025 01:00 ET | Source: BioVersys BASEL, Switzerland, March 26,…
Axsome Therapeutics Announces FOCUS Phase 3 Trial of Solriamfetol in Adults with Attention Deficit Hyperactivity Disorder (ADHD) Achieves Primary Endpoint
Demonstrated substantial and statistically significant improvement in ADHD symptoms as measured by…
Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
March 25, 2025 07:00 ET | Source: Predictive Oncology Inc. Company successfully…
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at AD/PD 2025
AC Immune Announces Upcoming Presentations and Industry Symposium on Active Immunotherapies at…
NMD Pharma presents preclinical data highlighting increased innervation of skeletal muscle with ClC-1 ion channel inhibition treatment in neuromuscular disease model
Company presented clinical and preclinical data at the MDA Conference last week…